Saturday 17 October 2026
Export CSLT’s income statement to Excel — free account
Castlight Health, inc.
CSLT Healthcare Health Information Services
Operating cash flow growth for ten consecutive years.
2.05
0.00
0.00%
Follow CSLT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 4 | 2 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
5.05 | 3.61 | 1.91 | 1.35 | 1.34 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(4.11) | (1.05) | (1.45) | (3.56) | (7.62) |
P/Operating CF |
(291.78) | (5,962.86) | 39.81 | 48.37 | 66.55 |
Beneish M-Score |
(3.29) | 0.43 | (2.60) | (2.71) | (4.14) |
P/B ratio |
4.89 | 2.25 | 1.53 | 1.12 | 1.59 |
Price to Tangible BV |
4.89 | 4.79 | 3.45 | 2.80 | 2.65 |
EV/Sales |
3.89 | 2.94 | 1.44 | 1.00 | 1.11 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 30.29 |
EV/Operating CF |
(10.40) | (16.57) | (12.11) | (8.21) | (29.17) |
EV/FCF |
(9.94) | (14.95) | (10.93) | (7.38) | (17.75) |
Quick Ratio |
2.66 | 2.02 | 2.04 | 1.65 | 2.36 |
Current Ratio |
2.89 | 2.09 | 2.11 | 1.74 | 2.47 |
Net Debt/EBITDA |
2.45 | 2.39 | 4.88 | 2.95 | (9.19) |
Debt/Assets |
0.00% | 1.77% | 1.28% | 0.57% | 0.00% |
Debt/Equity |
0.00 | 0.02 | 0.02 | 0.01 | 0.00 |
Asset Turnover |
0.60 | 0.60 | 0.59 | 0.58 | 0.72 |
Operating CF/Net income |
0.63 | 0.45 | 0.47 | 0.43 | 0.09 |
Capex/Depreciation |
(0.14) | (0.12) | (0.08) | (0.09) | (0.05) |
| (53.27%) | (33.11%) | (19.55%) | (21.77%) | (41.91%) | |
| (35.52%) | (23.75%) | (14.89%) | (16.12%) | (30.37%) | |
ROIC |
0.00% | (29.29%) | (20.68%) | (22.50%) | (52.59%) |
Return on Tangible Assets |
(60.15%) | (76.87%) | (65.51%) | (88.07%) | (111.46%) |
Average Days of Receivables |
54.75 | 60.64 | 62.58 | 79.97 | 78.97 |
Research and Development Expense of Revenue |
40.99% | 41.28% | 39.23% | 41.17% | 33.72% |
Selling, General and Administrative Expense of Revenue |
86.62% | 67.10% | 47.80% | 46.46% | 39.32% |
Intangible Assets out of Total Assets |
0.00 | 0.40 | 0.43 | 0.43 | 0.30 |
Share Based Compensation of Revenue |
21.53% | 18.18% | 11.59% | 10.47% | 8.48% |
Graham Net Nets |
0.17 | 0.11 | 0.16 | 0.13 | 0.21 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(11.92%) | (11.84%) | (13.36%) | (20.30%) | (32.31%) |
Free Cash Flow Yield |
(7.75%) | (5.45%) | (6.88%) | (10.02%) | (4.64%) |
Revenue per Share |
0.98 | 1.05 | 1.14 | 0.99 | 0.97 |
Operating CF per Share |
(0.37) | (0.19) | (0.13) | (0.12) | (0.04) |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.01) | (0.02) |
Free Cash Flow per Share |
(0.38) | (0.21) | (0.15) | (0.13) | (0.06) |
Cash per Share |
1.14 | 0.74 | 0.56 | 0.41 | 0.33 |
Shareholders Equity per Share |
1.01 | 1.69 | 1.41 | 1.19 | 0.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.01 | 1.69 | 1.41 | 1.19 | 0.82 |
Free Cash Flow |
(38.67) | (26.00) | (20.56) | (19.34) | (9.14) |
Working Capital |
92.29 | 62.26 | 56.65 | 40.56 | 50.47 |
Capital Expenditures |
(1.70) | (2.54) | (2.01) | (1.95) | (3.58) |
Net Current Asset Value |
85.81 | 50.94 | 48.99 | 25.56 | 41.88 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||
Depreciation/Fixed assets |
2.33 | 3.95 | 6.24 | 4.47 | 12.81 |
Cash ROIC |
(17.86%) | (8.39%) | (7.47%) | (8.28%) | (5.28%) |
Accounts Receivable Turnover |
7.16 | 7.19 | 6.42 | 4.92 | 4.65 |
Accounts Payable Turnover |
11.24 | 15.06 | 8.94 | 4.05 | 4.21 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
26.21 | 30.57 | 57.95 | 121.08 | 36.08 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
13.78 | 18.37 | 24.37 | 29.11 | 31.57 |
Average Payables |
2.84 | 3.10 | 6.73 | 14.58 | 12.37 |
Average Assets |
165.22 | 218.52 | 266.70 | 248.15 | 204.78 |
Average Common Equity |
110.16 | 156.76 | 203.11 | 183.77 | 148.37 |
Columns are period end dates